Ari Zimran

11.3k citations

267 papers · 7.6k indexed · 1 hit paper · h-index 46

Impact in

Physiology top 0.1%
- Lysosomal Storage Disorders Research
- Calcium signaling and nucleotide metabolism
Cell Biology top 0.1%
- Cellular transport and secretion

Papers in

Physiology 242
- Lysosomal Storage Disorders Research 240
Cell Biology 100
- Cellular transport and secretion 100

Co-authors: Deborah Elstein Aya Abrahamov Johannes M. F. G. Aerts Irith Hadas‐Halpern Gheona Altarescu Sonja van Weely Neal J. Weinreb Gregory M. Pastores
Journals: Blood Cells Molecules and Diseases (41 papers)Molecular Genetics and Metabolism (26 papers)American Journal of Hematology (15 papers)International Journal of Molecular Sciences (12 papers)Blood (12 papers)
Partner nations: Israel United States United Kingdom

In The Last Decade

Ari Zimran

257 papers receiving 7.4k citations

Hit Papers

align trajectories log scale

Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis 2000 · 592 citations

Peers

Countries citing papers authored by Ari Zimran

Since Specialization

Citations

This map shows the geographic impact of Ari Zimran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ari Zimran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ari Zimran more than expected).

Fields of papers citing papers by Ari Zimran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ari Zimran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ari Zimran. The network helps show where Ari Zimran may publish in the future.

Co-authors

The 25 scholars most cited alongside Ari Zimran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ari Zimran Line = papers co-authored together Ari Zimran links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Preimplantation Genetic Testing (PGT) to Reduce the Risk for GBA-Related Parkinson’s Disease: Expanding the Applications for Embryo Selection International Journal of Molecular Sciences ·N. M. Aksenova, Ari Zimran, Jeff Szer, Shoshana Revel‐Vilk, Gheona Altarescu	2025	0
2	Twelve Years of the Gaucher Outcomes Survey (GOS): Insights, Achievements, and Lessons Learned from a Global Patient Registry Journal of Clinical Medicine ·Deborah Elstein, Nadia Belmatoug, Bruno Bembi, Patrick Deegan, Irna Wulandari, Pilar Giraldo, Özlem Göker-Alpan, Derralynn Hughes, Heather Lau, Elena Lukina, Shoshana Revel‐Vilk, Ida Vanessa Döederlein Schwartz, H. B. C., Jaco Botha, Noga Gadir, N. Rădescu, Ari Zimran	2024	2
3	GBA1-Associated Parkinson’s Disease Is a Distinct Entity International Journal of Molecular Sciences ·Т. Тапкин, Mia Horowitz, H. B. C., Volha Skrahina, Jan Lukáš, Gilad Yahalom, Cristina Rosazza, Shoshana Revel‐Vilk, Özlem Göker-Alpan, Michal Becker‐Cohen, Sharon Hassin‐Baer, Per Svenningsson, Arndt Rolfs, Ari Zimran	2024	11
4	A Deep-Learning Approach to Spleen Volume Estimation in Patients with Gaucher Disease Journal of Clinical Medicine ·Ido Azuri, R. Lorey, 克已兼松, Debjyoti Mandal, Malakhanov, Yaron Caspi, H. B. C., Dan Wyttenbachius, Yaakov Applbaum, Ari Zimran, Shoshana Revel‐Vilk, Yonina C. Eldar	2023	2
5	Prodromal substantia nigra sonography undermines suggested association between substrate accumulation and the risk for GBA‐related Parkinson's disease European Journal of Neurology ·David Arkadir, Tama Dinur, (unknown), Shoshana Revel‐Vilk, محسن جعفرزاده کرچنکی, Norbert Brüggemann, Claudia Cozma, A. Rolfs, Ari Zimran	2019	12
6	Substrate Reduction Therapy for GBA1‐Associated Parkinsonism: Are We Betting on the Wrong Mouse? Movement Disorders ·Ellen Sidransky, David Arkadir, Peter Bauer, Tama Dinur, Grisel Lopez, Arndt Rolfs, Ari Zimran	2019	12
7	Outcomes after 8 years of eliglustat therapy for Gaucher disease type 1: Final results from the Phase 2 trial American Journal of Hematology ·Elena Lukina, Nora Watman, Marta Dragosky, Heather Lau, Elsa Ávila Arreguin, Hanna Rosenbaum, Ari Zimran, Meredith C. Foster, Sebastiaan J.M. Gaemers, Michel Peterschmitt	2018	49
8	Comparison of Bone Mineral Density by Dual-Energy X-Ray Absorptiometry and Bone Strength by Speed-of-Sound Ultrasonography in Adults With Gaucher Disease Journal of Clinical Densitometry ·E. Busko, Tama Dinur, Ehud Lebel, محسن جعفرزاده کرچنکی, Deborah Elstein, Ari Zimran	2016	1
9	Treatment-naïve Gaucher disease patients achieve therapeutic goals and normalization with velaglucerase alfa by 4 years in phase 3 trials Blood Cells Molecules and Diseases ·Ari Zimran, Deborah Elstein, Derlis Gonzalez, Elena Lukina, Hinawan T. Santoso, Heinz-Wilhelm Hübers, Hadhami Ben Turkia	2016	20
10	The incidence of Parkinsonism in patients with type 1 Gaucher disease: Data from the ICGG Gaucher Registry Blood Cells Molecules and Diseases ·Barry E. Rosenbloom, Manisha Balwani, Jeff M. Bronstein, Edwin H. Kolodny, Swati Sathe, A. R. Gwosdow, John S. Taylor, J. Alexander Cole, Ari Zimran, Neal J. Weinreb	2010	110
11	National health budgets for expensive orphan drugs: Gaucher disease in Israel as a model Blood Cells Molecules and Diseases ·Justin Sprague, Deborah Elstein, Avi Israeli, Raul Chertkoff, Ari Zimran	2006	11
12	Phenotypic Heterogeneity in Patients with Gaucher Disease and the N370S/V394L Genotype Genetic Testing ·Deborah Elstein, C. Ronald Scott, Marsha Zeigler, Aya Abrahamov, Ari Zimran	2005	7
13	Bone density changes with enzyme therapy for Gaucher disease Journal of Bone and Mineral Metabolism ·Ehud Lebel, Gaini Jia, A. Joseph Foldes, Eva Touriño, Menachem Itzchaki, Ari Zimran, Deborah Elstein	2004	34
14	Asymptomatic Gaucher Disease Implications for Large-Scale Screening Genetic Testing ·Joseph Azuri, Deborah Elstein, Amnon Lahad, Ayala Abrahamov, Irith Hadas‐Halpern, Ari Zimran	1998	41
15	Ethical considerations for enzyme replacement therapy in neuronopathic Gaucher disease Clinical Genetics ·Deborah Elstein, Ayala Abrahamov, Ari Zimran	1998	16
16	Ethical guidelines for enzyme therapy in neuronopathic Gaucher disease. PubMed ·Deborah Elstein, Arthur G. Steinberg, Aya Abrahamov, Ari Zimran	1997	2
17	Pulmonary function abnormalities in type I Gaucher disease European Respiratory Journal ·Eitan Kerem, Deborah Elstein, Aya Abrahamov, Yehiel Ziv, Irith Hadas‐Halpern, E Melzer, 何晓薇, David Branski, Ari Zimran	1996	52
18	The selective advantage of Gaucher's disease: TB or not TB? PubMed ·L. Salamba, Deborah Elstein, Raghdah Nahhas, Ari Zimran	1994	7
19	Incidence of hyperkalaemia induced by indomethacin in a hospital population. BMJ ·Ari Zimran, Mark Kramer, Ksenia Gorst, C Hershko	1985	31
20	Treatment with captopril for peripheral ischaemia induced by ergotamine. BMJ ·Ari Zimran, Joel Keith Faidley, Chaim Hershko	1984	3

About Ari Zimran

Ari Zimran is a scholar working on Physiology, Cell Biology, Epidemiology, Organic Chemistry and Hematology, having authored 267 papers that have together received 7.6k indexed citations. Recurring topics across this work include Lysosomal Storage Disorders Research (240 papers), Cellular transport and secretion (100 papers), Trypanosoma species research and implications (86 papers), Carbohydrate Chemistry and Synthesis (72 papers), Glycosylation and Glycoproteins Research (41 papers), Studies on Chitinases and Chitosanases (33 papers), Autoimmune and Inflammatory Disorders Research (17 papers) and Biochemical and Molecular Research (12 papers). The work is most often cited by research in Physiology (6.4k citations), Cell Biology (3.3k citations), Organic Chemistry (2.4k citations), Physiology (355 citations) and Epidemiology (2.4k citations). Ari Zimran has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Deborah Elstein, Aya Abrahamov, Johannes M. F. G. Aerts, Irith Hadas‐Halpern, Gheona Altarescu, Sonja van Weely, Neal J. Weinreb, Gregory M. Pastores, Shoshana Revel‐Vilk and Timothy M. Cox. Their work appears in journals such as Blood Cells Molecules and Diseases, Molecular Genetics and Metabolism, American Journal of Hematology, International Journal of Molecular Sciences and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact